Endo, Inc. Unveils TruDelivery, Enhancing Medication Safety and Efficiency

Endo

MALVERN, PA — Endo, Inc.’s Injectable Solutions business has rolled out its new TruDelivery® platform. This advanced ready-to-use (RTU) product lineup is designed to simplify the administration process for healthcare providers by eliminating the need for medication mixing, compounding, or diluting.

Scott Sims, Senior Vice President and General Manager of Injectable Solutions & Generics at Endo, emphasized the dual benefits of TruDelivery®. “TruDelivery delivers—without mixing, compounding, or diluting—so our customers can focus on quality patient care. Ready-to-administer and ready-to-use products may help reduce the risk of medication errors that can lead to unintended but catastrophic outcomes,” he stated.

This initiative aligns with the U.S. Food and Drug Administration’s (FDA) advocacy for manufacturing products that inherently reduce the possibility of medication errors. Traditionally, the preparation of medications involves several steps that, while necessary, increase the chances of mistakes. By streamlining this process, TruDelivery® aims to significantly cut down these risks.

The importance of such innovations cannot be overstated. Medication errors remain a leading concern in healthcare, with the potential to cause severe harm to patients. Through TruDelivery®, Endo offers a solution that not only enhances operational efficiency for hospitals and clinics but also plays a crucial role in improving patient safety.

Sims also revealed that Endo plans to expand its RTU portfolio. “There are dozens of ready-to-use projects in Endo’s pipeline that will join our current list of offerings over the next several years,” he shared. This commitment signifies a long-term investment in developing medications that are easier, safer, and more efficient to administer.

Endo’s TruDelivery® products include bivalirudin injection RTU bottles, dexmedetomidine HCl injection RTU bottles, ephedrine sulfate injection premixed vials, PREVDUO® injection prefilled syringes, and VASOSTRICT® RTU bottles. These products represent a significant advancement in the way medications are delivered in hospital settings, promising to reduce waste and costs, optimize convenience and workflow, and importantly, diminish the chance for preparation error.

READ:  Vishay Intertechnology Expands Optoelectronics Portfolio with Advanced IR Emitters

The launch of TruDelivery® marks a notable step forward in the push for safer healthcare practices. By addressing the root causes of medication errors, Endo, Inc. is at the forefront of improving the quality of patient care through innovation.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.